Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	S585-S588
Journal	Translational Cancer Research
Volume	8
DOIs	https://doi.org/10.21037/tcr.2019.06.39
State	Published - Dec 1 2019

Access to Document

@article{30c29be3d9cc486bb2d15fd9c63bc343,

title = "Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma",

author = "Yue Zhang and Shenhong Wu",

year = "2019",

month = dec,

day = "1",

doi = "10.21037/tcr.2019.06.39",

language = "English",

volume = "8",

pages = "S585--S588",

journal = "Translational Cancer Research",

issn = "2218-676X",

}

TY - JOUR

T1 - Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma

AU - Zhang, Yue

AU - Wu, Shenhong

PY - 2019/12/1

Y1 - 2019/12/1

UR - https://www.scopus.com/pages/publications/85078944932

U2 - 10.21037/tcr.2019.06.39

DO - 10.21037/tcr.2019.06.39

M3 - Comment/debate

AN - SCOPUS:85078944932

SN - 2218-676X

VL - 8

SP - S585-S588

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -